ZEO ScientifiX Reports Strong Revenue Growth for Three Months and Six Months Ended April 30, 2026
ZEO ScientifiX reported Q1 revenue of $2.58 million, up 124.6% year-over-year, driven by strong demand for its allogenic biologic products in Florida. Six-month revenue grew 79.9% to $4.03 million while gross margins held steady at 80%, helping reduce the net loss to $1.0 million from $2.6 million in the prior-year period.
Key figures
- Revenue
- 2581000
- Revenue Yoy
- 124.6%
- Net loss
- $1.0 million
- Gross margin
- 80.0%
- Six month revenue
- 4027000
- Prior year net loss
- $2.6 million
- Six month revenue yoy
- 79.9%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.